Evaluation of Nutritional Status and Fatigue in Patients With Multiple Sclerosis (NUTRISEP)

August 20, 2018 updated by: Lille Catholic University

Evaluation of the Nutritional Status of Patients With Multiple Sclerosis and Relationship With Fatigue

Multiple sclerosis (MS) is a chronic progressive neurological disease, the leading cause of disability after injury accidents in young adults. Among the many symptoms, fatigue is very common with a significant impact on quality of life. Also, the disability caused by multiple sclerosis can alter food intake and can cause nutritional deficiencies. Nutrients such as proteins, minerals (iron, calcium, magnesium), some vitamins (B12, 25 OHD) are often deficient in this population with consequences in physical performance such as endurance and muscle strength. We propose to study the link between fatigue and shortcomings encountered in a defined population of MS patients.

Study Overview

Study Type

Observational

Enrollment (Actual)

360

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Basse-Normandie
      • Caen, Basse-Normandie, France, 14033
        • Centre Hospitalier Universitaire de Caen
    • Nord Pas-de-Calais
      • Arras, Nord Pas-de-Calais, France, 62022
        • Centre Hospitalier d'Arras
      • Boulogne sur Mer, Nord Pas-de-Calais, France, 62200
        • Centre Hospitalier de Boulogne, Hôpital Duchenne
      • Calais, Nord Pas-de-Calais, France, 62100
        • Centre hospitalier de Calais
      • Lille, Nord Pas-de-Calais, France, 59000
        • Groupement des Hôpitaux de l'Institut Catholique de Lille
      • Lille, Nord Pas-de-Calais, France, 59037
        • Centre Hospitalier Regional Universitaire de Lille
      • Maubeuge, Nord Pas-de-Calais, France, 59600
        • Centre Hospitalier de Sambre-Avenois
      • Raimbeaucourt, Nord Pas-de-Calais, France, 59283
        • Centre Hélène Borel
      • Tourcoing, Nord Pas-de-Calais, France, 59208
        • Centre Hospitalier Dron de Tourcoing
      • Valenciennes, Nord Pas-de-Calais, France, 59322
        • Centre hospitalier de valenciennes
    • Nord-Pas De Calais
      • Douai, Nord-Pas De Calais, France, 59507
        • Centre Hospitalier de Douai
    • Picardie
      • Amiens, Picardie, France, 80054
        • Centre Hospitalier Universitaire d'Amiens

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients with MS defined according to the revised diagnostic criteria of Mac Donald, with ages between 18 to 65 years with an Expended disability status scale (EDSS) between 0 and 7 and followed in the services of neurology or physical medicine and rehabilitation.

Description

Inclusion Criteria:

  • Patients between 18 and 65 years old
  • Expended disability status scale (EDSS) between 0 and 7
  • Diagnosis of MS according to the revised criteria of McDonald
  • Clinically stable patients in the past 3 months
  • Coverage of the social insurance
  • Informed consent to participate

Exclusion Criteria:

  • Cognitive disorders that can hinder answering questionnaires
  • Presence of uncontrolled metabolic disease(s)
  • Malabsorption
  • Patients with a gastrostomy
  • Active cancer under treatment
  • Anorexia
  • Pregnancy or breast feeding
  • Severe psychiatric disorder(s)
  • No informed consent to participate
  • No coverage by the social insurance

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Multiple Sclerosis cases

All patients will undergo the following interventions

  • Gustatory sensitivity test using Taste strips
  • Blood sampling
  • Questionnaires
A blood sample will be taken from each patient and the following parameters will be assessed : magnesium, albumin, Vitamin B12, Vitamin D, Calcium, Iron.

16 Taste Strips impregnated with 4 flavors (sweet, sour, salty, bitter, each flavor present at 4 different concentrations), are offered to the patient one after the other in a so-called pseudorandomized sequence. The task of the patient is to choose one of the following answers: sweet / sour / salty / bitter / no taste.

Each correct answer is granted one point. In addition to the impregnated strips, two tasteless strips can be integrated in the examination at any point of time (no point)

Evaluation of the following parameters by validated questionnaires (name of the questionnaire in bracket):

  • Fatigue (EMIF-SEP)
  • Dysphagia (DYMUS)
  • Food intake (semi-structured questionnaire)
  • Depression (BDI-II)
  • Daily energy expenditure (NAP)
  • Visual analog scale to study quality of sleep

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Correlation between the score of fatigue EMIF-SEP and the dosage of nutrients in blood (vitamins, minerals, proteins) adjusted by the EDSS status
Time Frame: Baseline
The objective is to construct and validate a regression model between the scale of fatigue and biological variables
Baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Presence or absence of sociodemographic variables
Time Frame: Baseline
Baseline
Presence or absence of clinical manifestations
Time Frame: Baseline
Baseline
Level of physical activity and daily energy expenditure
Time Frame: Baseline
Baseline
Assessment of dysphagia according to the score of the Dymus Test
Time Frame: Baseline
Baseline
Score of the taste sensibility test
Time Frame: Baseline
Baseline
Score of the Beck depression inventory test
Time Frame: Baseline
This test is a 21-question multiple-choice self-report inventory for measuring the severity of depression
Baseline
Score of the visual analog scale for the evaluation of sleep quality
Time Frame: Baseline
Baseline
Score of the Nutrition and Eating Habits Questionnaire
Time Frame: Baseline
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Cécile Donzé, MD, Groupement des Hôpitaux de l'Institut Catholique de Lille

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2013

Primary Completion (Actual)

June 9, 2017

Study Completion (Actual)

June 9, 2017

Study Registration Dates

First Submitted

December 3, 2013

First Submitted That Met QC Criteria

December 6, 2013

First Posted (Estimate)

December 11, 2013

Study Record Updates

Last Update Posted (Actual)

August 21, 2018

Last Update Submitted That Met QC Criteria

August 20, 2018

Last Verified

August 1, 2018

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Multiple Sclerosis

Clinical Trials on Blood sampling

Subscribe